OrbiMed Capital GP VII LLC, 10% Owner at Passage BIO, Inc. (PASG), bought 178,600 shares at $5.60 ($963K) on 2022-01-14, disclosed to the SEC on 2022-01-20.
Open-market purchase of $963k PASG by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.60 | 10,300 | $58K | 6.0% |
| 2 | $5.60 | 10,300 | $58K | 6.0% |
| 3 | $5.46 | 114,700 | $626K | 65.0% |
| 4 | $5.11 | 43,300 | $221K | 23.0% |
| Total | $5.39 avg | 178,600 | $963K | 100% |
| Filing → |
| PASG | SELL | 2024-12-26 | $276K | — | Filing → |
| PASG | SELL | 2024-12-06 | $77K | — | Filing → |
| PASG | SELL | 2024-09-18 | $147K | — | Filing → |